CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
5 Jun, 20:00
NYSE NYSE
$
95. 93
+1.11
+1.1706%
$
116.08B Market Cap
11.4 P/E Ratio
0.64% Div Yield
9.6M Volume
7.87 Eps
$ 94.82
Previous Close
Add Transaction
Day Range
94.97 96.63
Year Range
58.5 98.43
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS Health (CVS) Beats Q2 Earnings, Narrows '24 EPS Outlook

CVS Health (CVS) Beats Q2 Earnings, Narrows '24 EPS Outlook

CVS Health (CVS) delivers a year-over-year improvement in revenues, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments.

Zacks | 1 year ago
CVS Health (CVS) Beats Q2 Earnings Estimates

CVS Health (CVS) Beats Q2 Earnings Estimates

CVS Health (CVS) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $2.21 per share a year ago.

Zacks | 1 year ago
CVS Health Corp shares under pressure after guidance downgrade

CVS Health Corp shares under pressure after guidance downgrade

Shares in CVS Health Corp (NYSE:CVS) were under pressure pre-market after it lowered full-year forecasts due to medical costs. The impact of the news was partially offset by a second-quarter earnings print that exceeded expectations.

Proactiveinvestors | 1 year ago
CVS Stock Falls Despite Earnings Beat. Blame Medicare.

CVS Stock Falls Despite Earnings Beat. Blame Medicare.

The healthcare giant cut its 2024 earnings outlook, citing higher medical costs in its insurance business.

Barrons | 1 year ago
CVS's stock drops after a revenue miss and lowered profit outlook, amid challenges in health care benefits

CVS's stock drops after a revenue miss and lowered profit outlook, amid challenges in health care benefits

Shares of CVS Health Corp. CVS, +0.92% dropped 2.3% in premarket trading Wednesday, after the drugstore chain beat second-quarter profit expectations but missed on revenue and lowered its full-year outlook, citing weakness in its health care benefits business. Net income fell to $1.77 billion, or $1.41 a share, from $1.90 billion, or $1.48 a share, in the same period a year ago.

Marketwatch | 1 year ago
CVS Health cuts 2024 profit forecast on elevated medical costs

CVS Health cuts 2024 profit forecast on elevated medical costs

CVS Health Corp on Wednesday cut its 2024 profit forecast, hit by increased medical costs at its health insurance unit as demand for healthcare services remained elevated.

Reuters | 1 year ago
Levi & Korsinsky Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CVS

Levi & Korsinsky Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CVS

NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Levi & Korsinsky Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline – CVS

Levi & Korsinsky Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline – CVS

NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Contact Levi & Korsinsky by September 10, 2024 Deadline to Join Class Action Against CVS Health Corporation(CVS)

Contact Levi & Korsinsky by September 10, 2024 Deadline to Join Class Action Against CVS Health Corporation(CVS)

NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
CVS Investors Have Opportunity To Lead CVS Health Corporation Securities Fraud Lawsuit With The Schall Law Firm

CVS Investors Have Opportunity To Lead CVS Health Corporation Securities Fraud Lawsuit With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE: CVS ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.

Accesswire | 1 year ago
What You Need To Know Ahead of CVS Earnings Wednesday

What You Need To Know Ahead of CVS Earnings Wednesday

Pharmacy giant CVS Health (CVS) reports second-quarter earnings ahead of the opening bell Wednesday, after its first-quarter results sent the company's stock sinking nearly 17%, its worst day of the year.

Investopedia | 1 year ago
Contact Levi & Korsinsky by September 10, 2024 Deadline to Join Class Action Against CVS Health Corporation(CVS)

Contact Levi & Korsinsky by September 10, 2024 Deadline to Join Class Action Against CVS Health Corporation(CVS)

NEW YORK, NY / ACCESSWIRE / August 6, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More